Investigation of rifampicin resistance mechanisms in brucella abortus using MS-driven comparative proteomics

Journal of Proteome Research

Volumn 11, Issue 4, 2012, Pages 2374-2385

  Sandalakis, Vassilios ^a,b   Psaroulaki, Anna ^a,b   De Bock, Pieter Jan ^c,d   Christidou, Athanasia ^a   Gevaert, Kris ^c,d   Tsiotis, Georgios ^a   Tselentis, Yiannis ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b Regional Laboratory of Public Health   (Greece)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Brucella abortus; comparative; in vitro; MIC; mutant; proteomics; resistance; rifampicin

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; STREPTOMYCIN; TETRACYCLINE; TIGECYCLINE;

ARTICLE; BACTERIAL STRAIN; BRUCELLA ABORTUS; BRUCELLOSIS; COMPUTER MODEL; CONTROLLED STUDY; CROSS RESISTANCE; DRUG SENSITIVITY; EPSILOMETER TEST; IN VITRO STUDY; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BRUCELLA ABORTUS; COMPUTER SIMULATION; DRUG RESISTANCE, BACTERIAL; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MUTATION; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; RIFAMPIN;

BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS;

EID: 84859569051     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201122w     Document Type: Article

References (69)

1. Moreno, E.; Moriyon, I. The Genus Brucella. In Prokaryotes, 3 rd ed.; Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, K. H., Stackebrandt, E., Eds.; Springer Science+Business Media, LLC: New York, NY, 2006; Vol. 5, pp 315-456.
2. Solera, J. Update on brucellosis: therapeutic challenges Int. J. Antimicrob. Agents 2010, 36 (Suppl. 1) S18-20
3. Campbell, E. A.; Korzheva, N.; Mustaev, A.; Murakami, K.; Nair, S.; Goldfarb, A.; Darst, S. A. Structural mechanism for rifampicin inhibition of bacterial rna polymerase Cell 2001, 104 (6) 901-12
4. Hardman, J. G.; Limbird, L. E.; Gilman, A. G., "Rifampin." The Pharmacological Basis of Therapeutics, 10 th ed.; The McGraw-Hill Companies: New York, 2001.
5. Williams, D. L.; Spring, L.; Collins, L.; Miller, L. P.; Heifets, L. B.; Gangadharam, P. R.; Gillis, T. P. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis Antimicrob. Agents Chemother. 1998, 42 (7) 1853-7
6. Matsiota-Bernard, P.; Vrioni, G.; Marinis, E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece J. Clin. Microbiol. 1998, 36 (1) 20-3
7. Taniguchi, H.; Aramaki, H.; Nikaido, Y.; Mizuguchi, Y.; Nakamura, M.; Koga, T.; Yoshida, S. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis FEMS Microbiol. Lett. 1996, 144 (1) 103-8
8. Marianelli, C.; Ciuchini, F.; Tarantino, M.; Pasquali, P.; Adone, R. Genetic bases of the rifampin resistance phenotype in Brucella spp J. Clin. Microbiol. 2004, 42 (12) 5439-43
9. Aubry-Damon, H.; Soussy, C. J.; Courvalin, P. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus Antimicrob. Agents Chemother. 1998, 42 (10) 2590-4
10. Adone, R.; Ciuchini, F.; Marianelli, C.; Tarantino, M.; Pistoia, C.; Marcon, G.; Petrucci, P.; Francia, M.; Riccardi, G.; Pasquali, P. Protective properties of rifampin-resistant rough mutants of Brucella melitensis Infect. Immun. 2005, 73 (7) 4198-204
11. Posadas, D. M.; Martin, F. A.; Sabio y Garcia, J. V.; Spera, J. M.; Delpino, M. V.; Baldi, P.; Campos, E.; Cravero, S. L.; Zorreguieta, A. The TolC homologue of Brucella suis is involved in resistance to antimicrobial compounds and virulence Infect. Immun. 2007, 75 (1) 379-89
12. Memish, Z.; Mah, M. W.; Al Mahmoud, S.; Al Shaalan, M.; Khan, M. Y. Brucella bacteraemia: clinical and laboratory observations in 160 patients J. Infect. 2000, 40 (1) 59-63
13. De Rautlin de la Roy, Y. M.; Grignon, B.; Grollier, G.; Coindreau, M. F.; Becq-Giraudon, B. Rifampicin resistance in a strain of Brucella melitensis after treatment with doxycycline and rifampicin J. Antimicrob. Chemother. 1986, 18 (5) 648-9
14. Wagner, M. A.; Eschenbrenner, M.; Horn, T. A.; Kraycer, J. A.; Mujer, C. V.; Hagius, S.; Elzer, P.; DelVecchio, V. G. Global analysis of the Brucella melitensis proteome: Identification of proteins expressed in laboratory-grown culture Proteomics 2002, 2 (8) 1047-60
15. Eschenbrenner, M.; Wagner, M. A.; Horn, T. A.; Kraycer, J. A.; Mujer, C. V.; Hagius, S.; Elzer, P.; DelVecchio, V. G. Comparative proteome analysis of Brucella melitensis vaccine strain Rev 1 and a virulent strain, 16M J. Bacteriol. 2002, 184 (18) 4962-70
16. Mujer, C. V.; Wagner, M. A.; Eschenbrenner, M.; Horn, T.; Kraycer, J. A.; Redkar, R.; Hagius, S.; Elzer, P.; Delvecchio, V. G. Global analysis of Brucella melitensis proteomes Ann. N.Y. Acad. Sci. 2002, 969, 97-101
17. Connolly, J. P.; Comerci, D.; Alefantis, T. G.; Walz, A.; Quan, M.; Chafin, R.; Grewal, P.; Mujer, C. V.; Ugalde, R. A.; DelVecchio, V. G. Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development Proteomics 2006, 6 (13) 3767-80
18. Al Dahouk, S.; Jubier-Maurin, V.; Scholz, H. C.; Tomaso, H.; Karges, W.; Neubauer, H.; Kohler, S. Quantitative analysis of the intramacrophagic Brucella suis proteome reveals metabolic adaptation to late stage of cellular infection Proteomics 2008, 8 (18) 3862-70
19. Al Dahouk, S.; Loisel-Meyer, S.; Scholz, H. C.; Tomaso, H.; Kersten, M.; Harder, A.; Neubauer, H.; Kohler, S.; Jubier-Maurin, V. Proteomic analysis of Brucella suis under oxygen deficiency reveals flexibility in adaptive expression of various pathways Proteomics 2009, 9 (11) 3011-21
20. Wang, Y.; Chen, Z.; Qiao, F.; Ying, T.; Yuan, J.; Zhong, Z.; Zhou, L.; Du, X.; Wang, Z.; Zhao, J.; Dong, S.; Jia, L.; Yuan, X.; Yang, R.; Sun, Y.; Huang, L. Comparative proteomics analyses reveal the virB of B. melitensis affects expression of intracellular survival related proteins PLoS One 2009, 4 (4) e5368
21. Lamontagne, J.; Forest, A.; Marazzo, E.; Denis, F.; Butler, H.; Michaud, J. F.; Boucher, L.; Pedro, I.; Villeneuve, A.; Sitnikov, D.; Trudel, K.; Nassif, N.; Boudjelti, D.; Tomaki, F.; Chaves-Olarte, E.; Guzman-Verri, C.; Brunet, S.; Cote-Martin, A.; Hunter, J.; Moreno, E.; Paramithiotis, E. Intracellular adaptation of Brucella abortus J. Proteome Res. 2009, 8 (3) 1594-609
22. Uzureau, S.; Lemaire, J.; Delaive, E.; Dieu, M.; Gaigneaux, A.; Raes, M.; De Bolle, X.; Letesson, J. J. Global analysis of quorum sensing targets in the intracellular pathogen Brucella melitensis 16 M J. Proteome Res. 2010, 9 (6) 3200-17
23. Paredes-Cervantes, V.; Flores-Mejia, R.; Moreno-Lafont, M. C.; Lanz-Mendoza, H.; Tello-Lopez, A. T.; Castillo-Vera, J.; Pando-Robles, V.; Hurtado-Sil, G.; Gonzalez-Gonzalez, E.; Rodriguez-Cortes, O.; Gutierrez-Hoya, A.; Vega-Ramirez, M. T.; Lopez-Santiago, R. Comparative proteome analysis of Brucella abortus 2308 and its virB type IV secretion system mutant reveals new T4SS-related candidate proteins J. Proteomics 2011, 74 (12) 2959-71
24. Neri, A.; Mignogna, G.; Fazio, C.; Giorgi, A.; Schinina, M. E.; Stefanelli, P. Neisseria meningitidis rifampicin resistant strains: analysis of protein differentially expressed BMC Microbiol. 2010, 10, 246
25. Lamontagne, J.; Beland, M.; Forest, A.; Cote-Martin, A.; Nassif, N.; Tomaki, F.; Moriyon, I.; Moreno, E.; Paramithiotis, E. Proteomics-based confirmation of protein expression and correction of annotation errors in the Brucella abortus genome BMC Genomics 2010, 11, 300
26. Lamontagne, J.; Butler, H.; Chaves-Olarte, E.; Hunter, J.; Schirm, M.; Paquet, C.; Tian, M.; Kearney, P.; Hamaidi, L.; Chelsky, D.; Moriyon, I.; Moreno, E.; Paramithiotis, E. Extensive cell envelope modulation is associated with virulence in Brucella abortu s J. Proteome Res. 2007, 6 (4) 1519-29
27. Gevaert, K.; Van Damme, J.; Goethals, M.; Thomas, G. R.; Hoorelbeke, B.; Demol, H.; Martens, L.; Puype, M.; Staes, A.; Vandekerckhove, J. Chromatographic isolation of methionine-containing peptides for gel-free proteome analysis: identification of more than 800 Escherichia coli proteins Mol. Cell. Proteomics 2002, 1 (11) 896-903
28. Ghesquiere, B.; Jonckheere, V.; Colaert, N.; Van Durme, J.; Timmerman, E.; Goethals, M.; Schymkowitz, J.; Rousseau, F.; Vandekerckhove, J.; Gevaert, K. Redox proteomics of protein-bound methionine oxidation Mol. Cell. Proteomics 2011, 10 (5 M110.006866
29. Ghesquiere, B.; Colaert, N.; Helsens, K.; Dejager, L.; Vanhaute, C.; Verleysen, K.; Kas, K.; Timmerman, E.; Goethals, M.; Libert, C.; Vandekerckhove, J.; Gevaert, K. In vitro and in vivo protein-bound tyrosine nitration characterized by diagonal chromatography Mol. Cell. Proteomics 2009, 8 (12) 2642-52
30. Colaert, N.; Helsens, K.; Impens, F.; Vandekerckhove, J.; Gevaert, K. Rover: a tool to visualize and validate quantitative proteomics data from different sources Proteomics 2010, 10 (6) 1226-9
31. Meier, P. S.; Utz, S.; Aebi, S.; Muhlemann, K. Low-level resistance to rifampin in Streptococcus pneumoniae Antimicrob. Agents Chemother. 2003, 47 (3) 863-8
32. Chain, P. S.; Comerci, D. J.; Tolmasky, M. E.; Larimer, F. W.; Malfatti, S. A.; Vergez, L. M.; Aguero, F.; Land, M. L.; Ugalde, R. A.; Garcia, E. Whole-genome analyses of speciation events in pathogenic Brucellae Infect. Immun. 2005, 73 (12) 8353-61
33. Martinez, J. L.; Rojo, F. Metabolic regulation of antibiotic resistance FEMS Microbiol. Rev. 2011, 35 (5) 768-89
34. Baudens, J. G.; Chabbert, Y. A. [Rifampicin: a bacteriostatic and bactericidal agent] Pathol. Biol. 1969, 17 (7) 392-7
35. Jung, Y. J.; Koh, Y.; Hong, S. B.; Chung, J. W.; Ho Choi, S.; Kim, N. J.; Kim, M. N.; Choi, I. S.; Han, S. Y.; Kim, W. D.; Yun, S. C.; Lim, C. M. Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia Crit. Care Med. 2010, 38 (1) 175-80
36. Deal, W. B.; Sanders, E. Efficacy of rifampin in treatment of meningococcal carriers N. Engl. J. Med. 1969, 281 (12) 641-5
37. Workowski, K. A.; Berman, S. M.; Douglas, J. M., Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies Ann. Intern. Med. 2008, 148 (8) 606-13
38. Green, M.; Li, K. I.; Wald, E. R.; Guerra, N.; Byers, C. Duration of rifampin chemoprophylaxis for contacts of patients infected with Haemophilus influenzae type B Antimicrob. Agents Chemother. 1992, 36 (3) 545-7
39. Troxler, R.; von Graevenitz, A.; Funke, G.; Wiedemann, B.; Stock, I. Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains Clin. Microbiol. Infect. 2000, 6 (10) 525-35
40. Varner, T. R.; Bookstaver, P. B.; Rudisill, C. N.; Albrecht, H. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia Ann. Pharmacother. 2011, 45 (7-8) 967-76
41. Zhou, Y. N.; Jin, D. J. The rpoB mutants destabilizing initiation complexes at stringently controlled promoters behave like "stringent" RNA polymerases in Escherichia coli Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (6) 2908-13
42. Inaoka, T.; Takahashi, K.; Yada, H.; Yoshida, M.; Ochi, K. RNA polymerase mutation activates the production of a dormant antibiotic 3,3- neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis J. Biol. Chem. 2004, 279 (5) 3885-92
43. Wang, Q.; Yue, J.; Zhang, L.; Xu, Y.; Chen, J.; Zhang, M.; Zhu, B.; Wang, H.; Wang, H. A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis J. Proteome Res. 2007, 6 (12) 4564-71
44. Schurig, G. G.; Roop, R. M., II; Bagchi, T.; Boyle, S.; Buhrman, D.; Sriranganathan, N. Biological properties of RB51; a stable rough strain of Brucella abortus Vet. Microbiol. 1991, 28 (2) 171-88
45. Falagas, M. E.; Bliziotis, I. A. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies Antimicrob. Agents Chemother. 2006, 50 (1) 22-33
46. Roushan, M. R.; Amiri, M. J.; Janmohammadi, N.; Hadad, M. S.; Javanian, M.; Baiani, M.; Bijani, A. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial J. Antimicrob. Chemother. 2010, 65 (5) 1028-35
47. Cocchi, S.; Bisi, L.; Codeluppi, M.; Venturelli, C.; Di Benedetto, F.; Ballarin, R.; Gerunda, G. E.; Rumpianesi, F.; Esposito, R.; Guaraldi, G. Brucellosis in a patient with end-stage liver disease undergoing liver transplantation: successful treatment with tigecycline Liver Transpl. 2010, 16 (10) 1215-6
48. Skalsky, K.; Yahav, D.; Bishara, J.; Pitlik, S.; Leibovici, L.; Paul, M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials BMJ [Br. Med. J.] 2008, 336 (7646) 701-4
49. Roushan, M. R. H.; Mohraz, M.; Janmohammadi, N.; Hajiahmadi, M. Efficacy of cotrimoxazole and rifampin for 6 or 8 weeks of therapy in childhood brucellosis Pediatr. Infect. Dis. J. 2006, 25 (6) 544-5
50. Skold, O. Sulfonamide resistance: mechanisms and trends Drug Resist Updates 2000, 3 (3) 155-60
51. Girgis, H. S.; Hottes, A. K.; Tavazoie, S. Genetic architecture of intrinsic antibiotic susceptibility PLoS One 2009, 4 (5) e5629
52. Hinz, A.; Lee, S.; Jacoby, K.; Manoil, C. Membrane proteases and aminoglycoside antibiotic resistance J. Bacteriol. 2011, 193 (18) 4790-7
53. Tribuddharat, C.; Fennewald, M. Integron-mediated rifampin resistance in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 1999, 43 (4) 960-2
54. Martinez, J. L.; Fajardo, A.; Garmendia, L.; Hernandez, A.; Linares, J. F.; Martinez-Solano, L.; Sanchez, M. B. A global view of antibiotic resistance FEMS Microbiol. Rev. 2009, 33 (1) 44-65
55. Perkins, A. E.; Nicholson, W. L. Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants J. Bacteriol. 2008, 190 (3) 807-14
56. Vranakis, I.; De Bock, P. J.; Papadioti, A.; Tselentis, Y.; Gevaert, K.; Tsiotis, G.; Psaroulaki, A. Identification of potentially involved proteins in levofloxacin resistance mechanisms in Coxiella burnetii J. Proteome Res. 2010, 10 (2) 756-62
57. Krulwich, T. A.; Lewinson, O.; Padan, E.; Bibi, E. Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study Nat. Rev. Microbiol. 2005, 3 (7) 566-72
58. Koprowski, P.; Kubalski, A. Bacterial ion channels and their eukaryotic homologues BioeEssays 2001, 23 (12) 1148-58
59. Parish, J.; Bentley, J. Relationships between bacterial drug resistance pumps and other transport proteins J. Mol. Evol. 1996, 42 (2) 281-93
60. Ferguson, A. D.; Kodding, J.; Walker, G.; Bos, C.; Coulton, J. W.; Diederichs, K.; Braun, V.; Welte, W. Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA Structure 2001, 9 (8) 707-16
61. Braun, V.; Pramanik, A.; Gwinner, T.; Koberle, M.; Bohn, E. Sideromycins: tools and antibiotics Biometals 2009, 22 (1) 3-13
62. Kohanski, M. A.; Dwyer, D. J.; Hayete, B.; Lawrence, C. A.; Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics Cell 2007, 130 (5) 797-810
63. Leonard, B. A.; Lopez-Goni, I.; Baldwin, C. L. Brucella abortus siderophore 2,3-dihydroxybenzoic acid protects brucellae from killing by macrophages Vet. Res. 1997, 28 (1) 87-92
64. Gonzalez Carrero, M. I.; Sangari, F. J.; Aguero, J.; Garcia Lobo, J. M. Brucella abortus strain 2308 produces brucebactin, a highly efficient catecholic siderophore Microbiology 2002, 148 (Pt 2) 353-60
65. Parent, M. A.; Bellaire, B. H.; Murphy, E. A.; Roop, R. M., II; Elzer, P. H.; Baldwin, C. L. Brucella abortus siderophore 2,3-dihydroxybenzoic acid (DHBA) facilitates intracellular survival of the bacteria Microb. Pathog. 2002, 32 (5) 239-48
66. Smolkina, T. V.; Zebrev, A. I.; Nikitin, A. V. [Effects of rifampicin and doxycycline on the production of hydrogen peroxide by macrophages] Antibiot. Khimioter. 1992, 37 (7) 17-9
67. Steele, K. H.; Baumgartner, J. E.; Valderas, M. W.; Roop, R. M., II. Comparative study of the roles of AhpC and KatE as respiratory antioxidants in Brucella abortus 2308 J. Bacteriol. 2010, 192 (19) 4912-22
68. Paiva, A. M.; Vanderwall, D. E.; Blanchard, J. S.; Kozarich, J. W.; Williamson, J. M.; Kelly, T. M. Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis Biochim. Biophys. Acta 2001, 1545 (1-2) 67-77
69. Woisetschlager, M.; Hodl-Neuhofer, A.; Hogenauer, G. Localization of the kdsA gene with the aid of the physical map of the Escherichia coli chromosome J. Bacteriol. 1988, 170 (11) 5382-4